Hemant Surgical Industries Profile
Key Indicators
- Authorised Capital ₹ 10.50 Cr
- Paid Up Capital ₹ 10.44 Cr
- Company Age 35 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 52.52 Cr
- Satisfied Charges ₹ 42.18 Cr
- Revenue Growth 5.41%
- Profit Growth 181.11%
- Ebitda 74.81%
- Net Worth 97.44%
- Total Assets 21.36%
About Hemant Surgical Industries
Hemant Surgical Industries Limited (HSIL) is a leading Public Limited Indian Non-Government Company incorporated in India on 27 March 1989 and has a history of 35 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Hemant Surgical Industries Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.50 Cr and a paid-up capital of Rs 10.44 Cr.
The company currently has active open charges totaling ₹52.52 Cr. The company has closed loans amounting to ₹42.18 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Hemant Surgical Industries Limited India are Meenal Ajmera as COMPANY SECRETARY and Kaushik Shah as Cfo. Hanskumar Shah, Hemant Shah, Sourabh Ajmera, and Three other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33110MH1989PLC051133
- Company No.
051133
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Mar 1989
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Hemant Surgical Industries Limited offer?
Hemant Surgical Industries Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Medical Tubes, Industrial Chemicals & Supplies, Disinfectant Chemicals, Diagnostic Medical Imaging Equipment, ECG Machine, Common Disease Medicines, IV Fluids, Surgical & ICU Equipments, Oxygen Mask, Flowmeter & Humidifier Bottle.
Who are the key members and board of directors at Hemant Surgical Industries?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hanskumar Shah  | Managing Director | 22-Feb-1994 | Current |
| Meenal Ajmera | Company Secretary | 05-Apr-2023 | Current |
| Kaushik Shah | CFO | 17-Dec-2022 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sourabh Ajmera | Director | 20-Dec-2022 | Current |
| Hemant Shah | Whole-Time Director | 19-Sep-2000 | Current |
| Nehal Karelia | Director | 20-Dec-2022 | Current |
| Pooja Kothari | Director | 03-Jan-2023 | Current |
| Kaushik Shah | Cfo and Whole-Time Director | 20-Dec-2022 | Current |
Financial Performance of Hemant Surgical Industries.
Hemant Surgical Industries Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.41% increase. The company also saw a substantial improvement in profitability, with a 181.11% increase in profit. The company's net worth Soared by an impressive increase of 97.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hemant Surgical Industries?
In 2023, Hemant Surgical Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ritco Logistics LimitedSourabh Ajmera is a mutual person
Wall Street Journal India Publishing Private LimitedSourabh Ajmera is a mutual person
Bmw Ventures LimitedSourabh Ajmera is a mutual person
Diaso Diagnostics LlpHanskumar Shah and Kaushik Shah are mutual person
- Ikigai Medequipments Private Limited
Hanskumar Shah and Kaushik Shah are mutual person
- Ikigai Services Private Limited
Hanskumar Shah and Kaushik Shah are mutual person
Charges (Loans)
₹52.52 Cr
₹42.18 Cr
Charges Breakdown by Lending Institutions
- Standard Chartered Bank : 25.77 Cr
- Yes Bank Limited : 19.92 Cr
- Hdfc Bank Limited : 2.90 Cr
- Sidbi : 2.47 Cr
- Others : 1.46 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jul 2024 | Yes Bank Limited | ₹9.21 M | Open |
| 15 Jun 2024 | Others | ₹5.00 M | Open |
| 30 Oct 2023 | Others | ₹1.85 M | Open |
| 24 Sep 2023 | Hdfc Bank Limited | ₹1.90 M | Open |
| 16 Sep 2023 | Hdfc Bank Limited | ₹2.13 Cr | Open |
How Many Employees Work at Hemant Surgical Industries?
Hemant Surgical Industries has a workforce of 59 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hemant Surgical Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemant Surgical Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
